Clinical Trial Update: Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of oxaliplatin, irinotecan, and S-1 in gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Stomach Neoplasm | Phase 2 | Status: COMPLETED